Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of halofuginone in plasma
An LC-MS/MS method was developed to quantitate the potential antitumor agent halofuginone in plasma. The assay uses 0.2 ml of plasma; chlorohalofuginone internal standard; acetonitrile for protein precipitation; a Phenomenex SYNERGI 4 micro Polar RP 80A (4 microm, 100 mm x 2 mm) column; an isocratic mobile phase of methanol:water:formic acid (80:20:0.02, v/v/v); and positive-ion electrospray ionization with selective reaction monitoring detection. Halofuginone eluted at approximately 2.4 min, internal standard eluted at approximately 2.9 min, and no endogenous materials interfered with their measurement. The assay was accurate, precise, and linear between 0.1 and 100 ng/ml. Halofuginone could be quantitated in dog plasma for at least 24 h after an i.v. dose of 0.1mg/kg. The assay is being used in ongoing pharmacokinetic studies of halofuginone
Parise, RA., Sparrow, BR., Merrill, JW., Grossi, I., Covey, JM., Peggins, JO., & Egorin, MJ. (2004). Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of halofuginone in plasma. Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 810(1), 35-40.